These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Therapy for lysosomal storage disorders. Beck M. IUBMB Life; 2010 Jan; 62(1):33-40. PubMed ID: 20014233 [Abstract] [Full Text] [Related]
5. Treatment options for lysosomal storage disorders: developing insights. van Gelder CM, Vollebregt AA, Plug I, van der Ploeg AT, Reuser AJ. Expert Opin Pharmacother; 2012 Nov; 13(16):2281-99. PubMed ID: 23009070 [Abstract] [Full Text] [Related]
6. Gene therapy for the lysosomal storage disorders. Cabrera-Salazar MA, Novelli E, Barranger JA. Curr Opin Mol Ther; 2002 Aug; 4(4):349-58. PubMed ID: 12222873 [Abstract] [Full Text] [Related]
8. Current and emerging therapies for the lysosomal storage disorders. Pastores GM, Barnett NL. Expert Opin Emerg Drugs; 2005 Nov; 10(4):891-902. PubMed ID: 16262569 [Abstract] [Full Text] [Related]
9. Current strategies in the management of lysosomal storage diseases. Heese BA. Semin Pediatr Neurol; 2008 Sep; 15(3):119-26. PubMed ID: 18708002 [Abstract] [Full Text] [Related]
10. [Treatment prospects of lysosomal storage disorders]. Reismann P, Tulassay Z. Orv Hetil; 2008 Jun 22; 149(25):1171-9. PubMed ID: 18547894 [Abstract] [Full Text] [Related]
11. Recent developments in therapeutic approaches for lysosomal storage diseases. Urbanelli L, Magini A, Polchi A, Polidoro M, Emiliani C. Recent Pat CNS Drug Discov; 2011 Jan 22; 6(1):1-19. PubMed ID: 21073432 [Abstract] [Full Text] [Related]
12. Gene therapy progress and prospects: gene therapy of lysosomal storage disorders. Cheng SH, Smith AE. Gene Ther; 2003 Aug 22; 10(16):1275-81. PubMed ID: 12883523 [Abstract] [Full Text] [Related]
13. Gene therapy for lysosomal storage diseases (LSDs) in large animal models. Haskins M. ILAR J; 2009 Aug 22; 50(2):112-21. PubMed ID: 19293456 [Abstract] [Full Text] [Related]
14. Treatment strategies for lysosomal storage disorders. Beck M. Dev Med Child Neurol; 2018 Jan 22; 60(1):13-18. PubMed ID: 29090451 [Abstract] [Full Text] [Related]
15. Enzyme replacement therapy for lysosomal diseases: lessons from 20 years of experience and remaining challenges. Desnick RJ, Schuchman EH. Annu Rev Genomics Hum Genet; 2012 Jan 22; 13():307-35. PubMed ID: 22970722 [Abstract] [Full Text] [Related]
16. Enzyme replacement therapy for lysosomal storage diseases. Ohashi T. Pediatr Endocrinol Rev; 2012 Oct 22; 10 Suppl 1():26-34. PubMed ID: 23330243 [Abstract] [Full Text] [Related]
17. Enzyme replacement and enhancement therapies: lessons from lysosomal disorders. Desnick RJ, Schuchman EH. Nat Rev Genet; 2002 Dec 22; 3(12):954-66. PubMed ID: 12459725 [Abstract] [Full Text] [Related]
18. Current state of the management of LSDs. Germain DP, Aggio M. Int J Clin Pharmacol Ther; 2009 Dec 22; 47 Suppl 1():S61-2. PubMed ID: 20040313 [No Abstract] [Full Text] [Related]
19. [Therapy of lysosomal storage diseases: update and perspectives]. Lara-Aguilar RA, Juárez-Vázquez CI, Medina-Lozano C. Rev Invest Clin; 2011 Dec 22; 63(6):651-8. PubMed ID: 23650678 [Abstract] [Full Text] [Related]
20. Treating lysosomal storage diseases with pharmacological chaperones: from concept to clinics. Parenti G. EMBO Mol Med; 2009 Aug 22; 1(5):268-79. PubMed ID: 20049730 [Abstract] [Full Text] [Related] Page: [Next] [New Search]